Valuation: Hugel, Inc.

Capitalization 2,846B 1.94B 1.65B 1.53B 1.43B 2.67B 179B 2.83B 17.51B 6.95B 84.28B 7.29B 7.14B 307B P/E ratio 2025 *
22.6x
P/E ratio 2026 * 17.4x
Enterprise value 2.34B 1.59M 1.36M 1.26M 1.17M 2.19M 146M 2.32M 14.36M 5.7M 69.16M 5.98M 5.86M 252M EV / Sales 2025 *
5.55x
EV / Sales 2026 * 4.46x
Free-Float
44.57%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+3.33%
1 week+8.88%
Current month+14.32%
1 month+14.57%
3 months-0.75%
6 months-25.04%
Current year+14.32%
More quotes
1 week 226,500
Extreme 226500
267,500
1 month 219,000
Extreme 219000
267,500
Current year 219,000
Extreme 219000
267,500
1 year 208,500
Extreme 208500
392,000
3 years 99,700
Extreme 99700
392,000
5 years 99,700
Extreme 99700
392,000
10 years 66,766
Extreme 66765.999
392,000
More quotes
Manager TitleAgeSince
Chief Executive Officer - 2025-10-12
Chief Tech/Sci/R&D Officer 54 2014-06-30
Chief Operating Officer 61 -
Director TitleAgeSince
Director/Board Member 62 2018-06-25
Director/Board Member 52 2022-03-31
Director/Board Member 54 2022-03-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+3.33%+8.88%+10.25%+82.35% 1.94B
-0.26%+2.80%+8.48%+3.24% 77.31B
+0.68%+2.33%-33.47%-39.80% 59.49B
-0.58%-3.09%+40.04%+234.20% 57.5B
+1.35%+80.20%+80.20%+80.20% 56.95B
-1.27%+4.36%+19.43%-41.22% 25.17B
-2.92%-3.97%+40.62%+22.17% 20.02B
-6.09%+16.45%+14.91%-75.27% 19.03B
+2.83%-6.48%+164.45%+94.20% 18.62B
-2.55%+2.11%+109.95%+813.97% 15.01B
Average -0.55%+1.92%+45.49%+117.40% 35.11B
Weighted average by Cap. -0.35%+0.20%+33.76%+79.81%
See all sector performances

Financials

2025 *2026 *
Net sales 421B 287M 244M 226M 212M 394M 26.38B 418M 2.59B 1.03B 12.46B 1.08B 1.05B 45.31B 495B 338M 287M 266M 249M 464M 31.02B 492M 3.04B 1.21B 14.65B 1.27B 1.24B 53.29B
Net income 143B 97.29M 82.74M 76.69M 71.67M 134M 8.94B 142M 876M 348M 4.22B 365M 357M 15.35B 181B 124M 105M 97.44M 91.06M 170M 11.36B 180M 1.11B 442M 5.36B 463M 454M 19.5B
Net Debt -511B -349M -297M -275M -257M -479M -32.04B -508M -3.14B -1.25B -15.13B -1.31B -1.28B -55.03B -641B -437M -372M -345M -322M -601M -40.18B -637M -3.94B -1.56B -18.97B -1.64B -1.61B -69.01B
More financial data * Estimated data
Logo Hugel, Inc.
Hugel Inc is a Korea-based company mainly engaged in the manufacture of biopharmaceuticals. The Company's product portfolio consists of botulinum toxins which used for treatment of benign essential blepharospasm and temporary improvement of moderate to severe glabellar lines including 50 unit types, 100 unit types and 200unit types; hyaluronic acid (HA) fillers which used for temporary removal of facial wrinkles including the chaeum premium No.1, the chaeum premium No.2, the chaeum premium No.3m the chaeum premium No.4, the chaeum MID 20A, the chaeum DEEP 20A, the chaeum SUB-Q 20A and the chaeum VOLUS 20A; wellages, blue roses and other cosmetics. The Company sells its products in domestic and overseas markets.
Employees
594
More about the company
Date Price Change Volume
26-01-23 263,500.00 +3.33% 118,460
26-01-22 255,000.00 +11.35% 256,725
26-01-21 229,000.00 -3.58% 80,142
26-01-20 237,500.00 +1.06% 68,935
26-01-19 235,000.00 -2.89% 87,505

End-of-day quote Korea S.E., January 22, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
263,500.00KRW
Average target price
352,600.00KRW
Spread / Average Target
+33.81%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A145020 Stock